The role of AI and smart clinical trials in accelerating drug development

In a featured article for Healthcare Business Today, Praveen Soti, Strategic Growth Leader for US Healthcare at Brillio, delves into the transformative role of artificial intelligence (AI) and generative AI (GenAI) in revolutionizing clinical trials and pharmaceutical innovation. As the traditional drug development process faces mounting challenges, ranging from delayed timelines and high R&D costs to inefficient patient recruitment, AI is emerging as a game changer.

From AI driven patient matching and adaptive trial designs to GenAI powered data analysis and drug repurposing, the article outlines how intelligent technologies are making clinical research faster, more efficient, and more personalized. It also explores real world applications by leading AI platforms and highlights how pharmaceutical companies are leveraging digital twins, synthetic datasets, and predictive modeling to accelerate discovery while maintaining data privacy and regulatory compliance.

With the global clinical trials market projected to grow significantly, now is the time for life sciences organizations to embrace AI.

Discover how AI is redefining the future of drug development.